Skip to main content

White paper: Multiple Myeloma

White paper

8 key applications of real-world data in multiple myeloma therapy development

Explore how real-world data is driving innovation in multiple myeloma research. Our white paper reveals 8 key applications of RWD, from improving clinical trials to advancing biomarker discovery. 

 

This white paper is free and can be downloaded and read at your convenience.

Gene therapy targeting cancer cells Modern research lab, ai generative

Lab data provides insights into new therapy opportunities

Multiple myeloma research is evolving rapidly, with real-world data (RWD) playing a critical role in driving therapeutic advancements. This lite paper outlines eight key applications of RWD in multiple myeloma therapy development, from improving clinical trial recruitment to optimizing treatment pathways and tracking biomarkers. Researchers and pharma professionals can explore how these datasets are providing real-time, actionable insights that enhance patient care and accelerate therapy development. 

With over 1.8 million patient records and rich data on more than 30 biomarkers, Quest Diagnostics’ multiple myeloma therapeutic dataset delivers the depth and precision needed for cutting-edge research. Gain a competitive edge by leveraging real-world evidence to inform your decisions and drive better outcomes for multiple myeloma patients. 

Download the lite paper today to discover how real-world data can help transform your multiple myeloma research.

Don't miss out on the latest in multiple myeloma research 

771

* indicates required